BARCO, AMBRA
BARCO, AMBRA
SCIENZE MEDICHE
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors
2022-01-01 De Benedetto, Ilaria; Barco, Ambra; Rossi, Marianna; Lapadula, Giuseppe; Lupia, Tommaso; Bonfanti, Paolo; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea
Cerebral white matter Hyperintensities in HIV–positive patients
2018-01-01 Trentalange A, Prochet A, Imperiale D, Cusato J, Tettoni M, Nunnari G, Barco A, Bonora S, Di Perri G, Calcagno A.
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen
2023-01-01 Stroffolini, Giacomo; Lazzaro, Alessandro; Barco, Ambra; Pirriatore, Veronica; Vai, Daniela; Giaccone, Claudia; Nigra, Marco; Atzori, Cristiana; Trunfio, Mattia; Bonora, Stefano; Di Perri G, Giovanni; Calcagno, Andrea
CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose
2018-01-01 Calcagno, Andrea*; Barco, Ambra; Trunfio, Mattia; Bonora, Stefano
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders
2022-01-01 Barco, A; Orlando, S; Stroffolini, G; Pirriatore, V; Lazzaro, A; Vai, D; Guastamacchia, G; Noce, G; Atzori, C; Trunfio, M; Bonora, S; Di Perri, G; Calcagno, A
Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis
2017-01-01 Marinaro, L; Merli, M; Barco, A; Alcantarini, C; Montrucchio, C; Tettoni, Mc; Vendemiati, G; Bocchino, G; De Nicolo', A; Hasson, H; D'Avolio, A; Foppa, C.U.; Di Perri, G; Bonora, S.
Pharmacokinetics of simeprevir and risk of skin reactions in patients with co-infection HIV/HCV with or without a protease inhibitor containing HAART
2016-01-01 Marinaro, L.; Barco, A.; Vendemiati, G.; Merli, M.; Alcantarini, C.; Patti, F.; Airaudo, A.; Favata, F.; Milesi, M.; Cusato, J.; Tettoni, M.C.; Trentini, L.; Hasson, H.; Uberti Foppa, C.; D'Avolio, A.; Di Perri, G.; Bonora, S.
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?
2021-01-01 Trentalange, Alice; Borgogno, Enrica; Motta, Ilaria; Antonucci, Miriam; Pirriatore, Veronica; Costa, Cecilia; Rossi, Giovanni; Barco, Ambra; De Nicolò, Amedeo; Piccioni, Pavilio; D'Avolio, Antonio; Bonora, Stefano; Perri, Giovanni Di; Calcagno, Andrea
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors | 2022 | De Benedetto, Ilaria; Barco, Ambra; Rossi, Marianna; Lapadula, Giuseppe; Lupia, Tommaso; Bonfanti, Paolo; Bonora, Stefano; Di Perri, Giovanni; Calcagno, Andrea | |
| Cerebral white matter Hyperintensities in HIV–positive patients | 2018 | Trentalange A, Prochet A, Imperiale D, Cusato J, Tettoni M, Nunnari G, Barco A, Bonora S, Di Perri G, Calcagno A. | |
| Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen | 2023 | Stroffolini, Giacomo; Lazzaro, Alessandro; Barco, Ambra; Pirriatore, Veronica; Vai, Daniela; Giaccone, Claudia; Nigra, Marco; Atzori, Cristiana; Trunfio, Mattia; Bonora, Stefano; Di Perri G, Giovanni; Calcagno, Andrea | |
| CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose | 2018 | Calcagno, Andrea*; Barco, Ambra; Trunfio, Mattia; Bonora, Stefano | |
| Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders | 2022 | Barco, A; Orlando, S; Stroffolini, G; Pirriatore, V; Lazzaro, A; Vai, D; Guastamacchia, G; Noce, G; Atzori, C; Trunfio, M; Bonora, S; Di Perri, G; Calcagno, A | |
| Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis | 2017 | Marinaro, L; Merli, M; Barco, A; Alcantarini, C; Montrucchio, C; Tettoni, Mc; Vendemiati, G; Bocchino, G; De Nicolo', A; Hasson, H; D'Avolio, A; Foppa, C.U.; Di Perri, G; Bonora, S. | |
| Pharmacokinetics of simeprevir and risk of skin reactions in patients with co-infection HIV/HCV with or without a protease inhibitor containing HAART | 2016 | Marinaro, L.; Barco, A.; Vendemiati, G.; Merli, M.; Alcantarini, C.; Patti, F.; Airaudo, A.; Favata, F.; Milesi, M.; Cusato, J.; Tettoni, M.C.; Trentini, L.; Hasson, H.; Uberti Foppa, C.; D'Avolio, A.; Di Perri, G.; Bonora, S. | |
| Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? | 2021 | Trentalange, Alice; Borgogno, Enrica; Motta, Ilaria; Antonucci, Miriam; Pirriatore, Veronica; Costa, Cecilia; Rossi, Giovanni; Barco, Ambra; De Nicolò, Amedeo; Piccioni, Pavilio; D'Avolio, Antonio; Bonora, Stefano; Perri, Giovanni Di; Calcagno, Andrea |